Evaluation of efficacy of GCSF in reducing neutropenia among carcinoma patients undergoing anti-cancer chemotherapy. A prospective cohort study.
The use of granulocyte colony-stimulating factor (GCSF) to control febrile neutropenia (FN) caused by anti-cancer chemotherapy is well documented but it still needs to evaluated with respect to the specific type of cancer and chemotherapeutic agents. The present study evaluates the efficacy of adjun...
Saved in:
Main Authors: | Maria Kakar, Sami Ullah, Amjad Khan, Shabnam Nazir |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2025-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0315435 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of efficacy of GCSF in reducing neutropenia among carcinoma patients undergoing anti-cancer chemotherapy. A prospective cohort study
by: Maria Kakar, et al.
Published: (2025-01-01) -
Neutropenia and Neutropenic Complications in ABVD Chemotherapy for Hodgkin Lymphoma
by: Bhanu Vakkalanka, et al.
Published: (2011-01-01) -
Evaluation of ior ® Leukocim efficacy on patients with Neutropenia.
by: Ana María Ramos Cedeño, et al.
Published: (2007-12-01) -
Dynamics of a Breast Cancer Model for Neutropenia Case due to Chemotherapy Effects
by: M. Ivan Ariful Fathoni, et al.
Published: (2021-01-01) -
A Case of Autoimmune Neutropenia in a Patient Undergoing Breast Cancer Surgery
by: Mio Adachi, et al.
Published: (2024-01-01)